Professor Mandy MacLean

Mandy obtained her PhD in Pharmacology from the University of Edinburgh in 1985 and then spend a year in the USA and three years in Cambridge before moving to The University of Glasgow in 1989. Mandy joined The University of Strathclyde in 2019. Her research has focused on the role of serotonin and estrogen in the development of pulmonary arterial hypertension (PAH). She won the 2017 Reynold Spector Award for Clinical Pharmacology from the American Society for Pharmacology and Experimental Therapeutics (ASPET). Other research awards include a Royal Society Wolfson Research Merit Award in 2010 and a Royal Society Leverhulme Trust Senior Research Fellowship in 2013. In 2013 she was elected as a Fellow of The Royal Society of Edinburgh (FRSE) and awarded the British Pharmacological Society AstraZeneca Prize for Women in Pharmacology. She was elected as an Ordinary Member and Trustee of Council for the Royal Society of Edinburgh and is Vice-President (Life Sciences) of the Royal Society of Edinburgh (until 2021). Mandy received an MBE in the 2010 Queen’s New Year’s Honours list for her career and public engagement activities. She plays a key role in the University’s public engagement agenda including co-hosting monthly events for Glasgow’s Cafe Scientifique (since 2004). In 2018 she was made a Fellow of the Academy of Medical Sciences and was appointed the Scottish Champion for the Academy of Medical Sciences. She was appointed onto Council of The Academy of Medical Sciences in December 2020.